YuanBio Venture Capital

YuanBio Venture Capital

Overview

Yuanbio Venture Capital is a leading healthcare investment firm focusing on early and growth stage investment opportunities. Headquartered in Suzhou bioBay, they look for highly innovative companies across the country and keeps a global view on the development of healthcare industry . Till now, there are over 190 companies in their investment portfolio, covering biotech, medical devices, IVD and healthcare services, and 19 of the companies are listed on the SRAT Board, HKEX and Nasdaq, delivering outstanding performance to their funds . YuanBio has been awarded as one of the top healthcare VCs in China for many consecutive years .

Year Founded

2013

Portfolio Companies

34

Investments

CompanyDateStageLead
Allink BiotherapeuticsDec 2025Series A ExtensionCo-investor
北京星源智机器人科技有限公司Dec 2025AngelCo-investor
AusperBioSep 2025Series B ExtensionCo-investor
北京星源智机器人科技有限公司Sep 2025AngelCo-investor
BCIFlexAug 2025Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersJiangsu
Year Founded2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.